Gilead Sciences, in collaboration with the Carlos III Health Institute (ISCIII), held the award ceremony for the 10th Edition of…
BBVA Foundation
Now published in Annals of Oncology (1), updated meta-analysis provides insights into the efficacy of adoptive cell therapy with tumor-infiltrating…
VHIO consolidates its advanced therapy programme to develop new innovative treatments against cancer
The 1st VHIO-BBVA Foundation International Symposium on Cell-based Therapies in Oncology , organised by Dr. Alena Gros, head of the…
Developed by VHIO investigators, VIGex is a gene expression signature that classifies solid tumors into three categories based on the…
Non-canonical proteins are unconventional protein products that are not part of the known protein-coding genome repertoire. They arise from unexpected…
